EASL policy statement on the use of COVID-19 vaccines in people with chronic liver disease, hepatobiliary cancer, and liver transplant recipients
This policy statement is intended for the general public, affected communities, and policymakers.
In parallel, intended for healthcare professionals, an article titled “EASL position paper on the use of COVID-19 vaccines in people with chronic liver diseases, hepatobiliary cancer and liver transplant recipients” was published, 6 February 2021, in the Journal of Hepatology.
Download the lay version, policy statement.
Download the position paper for healthcare professionals.